Pending US vaccine decisions as Kennedy takes top health job

Item 1 of 2 Robert F. Kennedy Jr., U.S. President Trump’s nominee to be Secretary of Health and Human Services, testifies before a Senate Finance Committee confirmation hearing on Capitol Hill in Washington, U.S., January 29, 2025. REUTERS/Nathan Howard/File Photo

[1/2]Robert F. Kennedy Jr., U.S. President Trump’s nominee to be Secretary of Health and Human Services, testifies before a Senate Finance Committee confirmation hearing on Capitol Hill in Washington, U.S., January 29, 2025. REUTERS/Nathan Howard/File Photo Purchase Licensing Rights

, opens new tab

Feb 13 (Reuters) – Robert F. Kennedy Jr, a vaccine critic who has pledged to tackle chronic disease, was confirmed by the U.S. Senate as Health Secretary on Thursday, after overcoming resistance from the medical establishment and members of Congress with promises to limit his role in vaccine policy.

As head of the health department, which oversees more than $3 trillion in healthcare spending, Kennedy would have authority over agencies including the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).

Here are some pending regulatory decisions and meetings on vaccines coming up over the next few months:

Sign up here.

Reporting by Mariam Sunny in Bengaluru; Editing by Anil D’Silva

Our Standards: The Thomson Reuters Trust Principles.

, opens new tab

Leave a Reply

Your email address will not be published. Required fields are marked *